- Quarter end
- 30 Sep 2025
- the date the book describes
- Filed
- 17 Nov 2025
- latest of these filings; the earliest 12 Nov 2025
- Managers listing it
- 12
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q2 2025 and Q3 2025; 9 listed it in both
- Shares listed
- 360,574,898
- combined, among listed positions
- Reported value
- $9.4bn
- combined, at the quarter end
Among the 95 comparable managers: 6 buyers (opened or added shares) and 6 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing KHC in Q3 2025
12 of 12 holders
Largest increases and reductions, by shares
Increases
- Marshall Wace LLPexisting position · 4,011,448 shares now+2,131,167
- Verition Fund Management LLCexisting position · 898,401 shares now+464,663
- Invesco Ltdexisting position · 17,855,352 shares now+270,678
- Caxton Associates LLPnew position · 118,858 shares now+118,858
- Maverick Capital Ltdnew position · 65,900 shares now+65,900
Reductions
- Arrowstreet Capital LPexisting position · 4,463,931 shares now-2,900,203
- Quantbot Technologies LPexisting position · 199,378 shares now-308,566
- Brevan Howard Capital Management LPexisting position · 98,560 shares now-73,282
- Southeastern Asset Management Incexisting position · 3,637,374 shares now-36,887
- GAMCO Investors Incexisting position · 118,578 shares now-35,156
New positions and exits
New (2)
Exited (1)
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2015 | 27 | $29.5bn | n.a. | n.a. |
| Q4 2015 | 27 | $29.8bn | n.a. | n.a. |
| Q1 2016 | 29 | $33.0bn | n.a. | n.a. |
| Q2 2016 | 25 | $37.1bn | n.a. | n.a. |
| Q3 2016 | 25 | $37.8bn | n.a. | n.a. |
| Q4 2016 | 22 | $36.6bn | n.a. | n.a. |
| Q1 2017 | 29 | $38.0bn | n.a. | n.a. |
| Q2 2017 | 31 | $36.0bn | n.a. | n.a. |
| Q3 2017 | 30 | $32.5bn | n.a. | n.a. |
| Q4 2017 | 24 | $32.6bn | n.a. | n.a. |
| Q1 2018 | 18 | $25.8bn | n.a. | n.a. |
| Q2 2018 | 17 | $25.8bn | n.a. | n.a. |
| Q3 2018 | 20 | $21.9bn | n.a. | n.a. |
| Q4 2018 | 19 | $16.9bn | n.a. | n.a. |
| Q1 2019 | 13 | $11.9bn | n.a. | n.a. |
| Q2 2019 | 19 | $11.7bn | n.a. | n.a. |
| Q3 2019 | 13 | $10.0bn | n.a. | n.a. |
| Q4 2019 | 9 | $11.0bn | n.a. | n.a. |
| Q1 2020 | 13 | $8.7bn | n.a. | n.a. |
| Q2 2020 | 10 | $11.2bn | n.a. | n.a. |
| Q3 2020 | 12 | $10.7bn | n.a. | n.a. |
| Q4 2020 | 11 | $13.2bn | n.a. | n.a. |
| Q1 2021 | 13 | $15.6bn | n.a. | n.a. |
| Q2 2021 | 13 | $15.9bn | n.a. | n.a. |
| Q3 2021 | 9 | $14.0bn | n.a. | n.a. |
| Q4 2021 | 13 | $13.6bn | n.a. | n.a. |
| Q1 2022 | 16 | $15.3bn | n.a. | n.a. |
| Q2 2022 | 24 | $15.6bn | n.a. | n.a. |
| Q3 2022 | 19 | $13.2bn | n.a. | n.a. |
| Q4 2022 | 14 | $16.2bn | n.a. | n.a. |
| Q1 2023 | 15 | $15.3bn | n.a. | n.a. |
| Q2 2023 | 19 | $14.1bn | n.a. | n.a. |
| Q3 2023 | 20 | $13.6bn | n.a. | n.a. |
| Q4 2023 | 23 | $15.1bn | 10 | 12 |
| Q1 2024 | 15 | $14.7bn | 6 | 11 |
| Q2 2024 | 16 | $12.3bn | 14 | 2 |
| Q3 2024 | 14 | $13.4bn | 4 | 8 |
| Q4 2024 | 17 | $11.4bn | 6 | 9 |
| Q1 2025 | 15 | $11.2bn | 7 | 7 |
| Q2 2025 | 13 | $9.5bn | 7 | 6 |
| Q3 2025 | 12 | $9.4bn | 6 | 6 |
| Q4 2025 | 11 | $9.6bn | 23 | 11 |
| Q1 2026 | 13 | $8.8bn | 20 | 16 |
| Q2 2026 | 13 | $9.2bn | 18 | 15 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
KHC and PM →KHC and KO →KHC and COST →Choose a stock to compare with KHC →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own KHC, latest filings →Back to the 13F Explorer →